References
- Neu HC. Side effects of antimicrobial therapy. In: Infectious Diseases. Ed S.L. Gorbach, J. Bartlett, N Blacklow. Philadelphia: WB Saunders, 1992: 340.
- AP Ball. The Quinolones—history and overview. In: The Quinolones, 3rd Edition, Ed V.T. Andriole. San Diego, USA Academic Press, 2001: Chap.l.
- Whitehouse A, Brar J, Kowalsky S et al. The Avelox Clinical Experience Study, a post-marketing observational study. 1st Int Conf On Resistant Gram-Positive Infections, San Antonio, Tx, Dec. 2001, Abst 1-13.
- Von Seggern K, Russo R Wikler M. A novel approach to postmarketing surveillance, the Tequin Clinical Experience Study. 41st ICAAC, Sept. 2000, Toronto, Canada, Abst 2216.
- Griffin JP. Survey of the spontaneous adverse drug reac-tion reporting schemes in fifteen countries. Br J Clin Pharmacol 1980; 22: 83s-100s.
- Figueiras A, Tato F, Fontainas J, Gestal-Otero JJ. Influence of physicians' attitudes on reporting adverse drug events: a case-control study. Med Care 1999; 37 (8): 809–14.
- Freedom of Information Act, Food and Drug Administration, Bethesda, MD, 1998-2000.
- Kubin R, Reiter C. Safety update of moxifloxacin: a cur-rent review of clinical trials and post-marketing observational studies. 41st ICAAC, Sept. 2000, Toronto, Canada, Abst 820.
- Hollister AS. Moxifloxacin has a favourable cardiovascu-lar safety profile in patients taking concomitant QTc prolong-ing drugs. 41st ICAAC, Sept. 2000, Toronto, Canada Abst 818.
- Landen H, Moller M, Tillotson GS, et al. Clinical expe-rience in Germany of treating community-acquired respiratory infections with the new 8-methoxy-fluroquinolone, moxi-floxacin. J Int Med Res 2001; 29: 51–60.
- Freedom of Information Act, FDA, Bethesda, MD, 2001.
- Mandell L, Choudhri S, Kubin R. Safety assessment of sequential i.v./p.o. moxifloxacin in the treatment of patients with community-acquired pneumonia. 11th Eur Cong Chemother Clin Microbiol Infect Dis, 2001, Istanbul, Abst. P863.
- Gatifloxacin (Tequin) Package Insert, October 2001, Bristol-Myers Squibb, Princeton, NJ.
- Levofloxacin (Levaquin) Package Insert, November 2001, Ortho McNeil, Raritan, NJ.
- Henann NE, Zambre MF. Gatifloxacin-associated acute hepatitis. Pharmacotherapy 2001; 21: 1579–82.